Thermogravimetric studies of a nasal preparation with an interleukin-1β (IL-1Ra) antagonist

Thermogravimetric studies of a nasal preparation with an interleukin-1β (IL-1Ra) antagonist

Interleukin-1 receptor antagonist (IL-1Ra) is an active pharmaceutical ingredient obtained by the method of gene transformation of Escherichia coli, provides a neuroprotective effect, namely – inhibition of oxidative modification of proteins, normalization of functional activity of mitochondrial ene...

Full description

Bibliographic Details
Main Author:	B. S. Burlaka
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2021-03-01
Series:	Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:	il-1ra thermogravimetry nasal dosage form
Online Access:	http://pharmed.zsmu.edu.ua/article/view/226780/226523

Similar Items

Selection of excipients for the purpose of creating an intranasal gel of interleukin-1 receptor antagonist β (IL-1ra)
by: B. S. Burlaka, et al.
Published: (2020-08-01)

Optimization of the composition of a nasal medicine with interleukin-1 antagonist β
by: B. S. Burlaka
Published: (2021-02-01)

Differences in the Levels of Interleukin-1β (IL-1β) and Interleukin-1 Receptor Antagonist (IL-1ra) in Children with Status Epilepticus and Febrile Seizure
by: Fita Shofiyah, et al.
Published: (2017-09-01)

Severity evaluation of bhronic polypous rhinosinusitis based on changes of IL-1β cytokine and IL-1ra concentrations in nasal secretions
by: E. V. Bezrukova, et al.
Published: (2020-01-01)

Study of excipients influence on the noopept releasing from the nasal dosage form
by: B. S. Burlaka, et al.
Published: (2019-12-01)

Avaliação da expressão de interleucina 1 beta (IL-1β) e antagonista do receptor de interleucina 1 (IL-1Ra) em pacientes com hanseníase Evaluation of the expression of interleukin 1 beta(IL-1β) and interleukin 1 receptor antagonist (IL-1Ra) in leprosy patients
by: Rosane Dias Costa, et al.
Published: (2008-01-01)

Study of surfactants influence on the noopept releasing from the nasal dosage form
by: B. S. Burlaka, et al.
Published: (2020-05-01)

Thermogravimetric investigation of a new intranasal gel with noopept
by: B. S. Burlaka
Published: (2019-12-01)

Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture
by: Shikhar Mehta, et al.
Published: (2019-11-01)

IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes
by: Fen Wang, et al.
Published: (2019-07-01)

Thermogravimetric investigations of nasal gel with diltiazem
by: L. K. Kuchina, et al.
Published: (2015-12-01)

INTERLEUKIN-1, INTERLEUKIN-6, AND ANTAGONIST INTERLEUKIN-1RECEPTOR AS MEMORY IMPAIRMENT RISK FACTOR IN COMPLEX PARTIAL EPILEPSY
by: D. P. G. Purwa-Samatra, et al.
Published: (2013-07-01)

Minimally-invasive Sampling of Interleukin-1α and Interleukin-1 Receptor Antagonist from the Skin: A Systematic Review of In vivo Studies in Humans
by: Denise Falcone, et al.
Published: (2017-06-01)

IMBALANCE OF IL -1β И IL -1RA CYTOKINES IN BLOOD SERUM AND BRONCHOALVEOLAR LAVAGE IN COPD PATIENTS
by: E. A. Surkova, et al.
Published: (2014-07-01)

The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms
by: Baumann Ralf, et al.
Published: (2012-08-01)

Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome
by: Valentina Parisi, et al.
Published: (2020-02-01)

THERMOGRAVIMETRIC INVESTIGATIONS OF VAGINAL SUPPOSITORY WITH THYME OIL
by: N. V. Melnikova, et al.
Published: (2015-04-01)

Ex-Vivo and In-Vivo Assessment of Cyclamen europaeum Extract After Nasal Administration
by: Francisco Fernández-Campos, et al.
Published: (2019-08-01)

Impact of the Functional VNTR Variants of the Interleukin-1 Receptor Antagonist and Interleukin-4 Genes on Oral Squamous Cell Carcinoma
by: Özge Gümüşay, et al.
Published: (2019-05-01)

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance
by: Hanna Grauers Wiktorin, et al.
Published: (2021-01-01)

Non-viral Gene Delivery of Interleukin-1 Receptor Antagonist Using Collagen-Hydroxyapatite Scaffold Protects Rat BM-MSCs From IL-1β-Mediated Inhibition of Osteogenesis
by: William A. Lackington, et al.
Published: (2020-10-01)

The use of machine learning methods in the development of nasal dosage forms with cerebroprotective action
by: B. S. Burlaka, et al.
Published: (2021-07-01)

Genetic analysis of the relation between IL2RA/IL2RB and rheumatoid arthritis risk
by: Yonghui Yang, et al.
Published: (2019-07-01)

IL-7Ra Association and Genotype-Dependent Severity and Response to IFN-β Therapy in Multiple Sclerosis
by: Majid Hosseinzadeh, et al.
Published: (2019-07-01)

Kinetic parameters from thermogravimetric analysis.
Published: (1975)

Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia
by: Min-Jer Hsu, et al.
Published: (2012-01-01)

Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis
by: Luzia Maria de-Oliveira-Pinto, et al.
Published: (2012-02-01)

Analysis of plasma multiplex cytokines and increased level of IL-10 and IL-1Ra cytokines in febrile seizures
by: Kyungmin Kim, et al.
Published: (2017-10-01)

Polymorphism analysis of IL17RA gene to the IL17RA concentration and chronicity differences in nefritis lupus NL patients
by: Mahrus Ismail, et al.
Published: (2014-12-01)

From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology
by: Jean-Michel Dayer
Published: (2018-05-01)

Organic binder removal of multilayer ceramics using a rate-controlled thermogravimetric analyzer
by: Witt, Jason R.
Published: (2008)

Comparison of The Effect of Intra-Articular Injection of Autologous (Orthokine) Interleukin-1 (IL-1Ra) Receptor Antagonist and Hyaluronic Acid in Pain Control of Knee Osteoarthritis
by: Masoud Hashemi, et al.
Published: (2019-08-01)

IL-22Ra1 is induced during influenza infection by direct and indirect TLR3 induction of STAT1
by: K. D. Hebert, et al.
Published: (2019-08-01)

The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion
by: Lisa Schneider, et al.
Published: (2021-05-01)

Interleukin-31, Interleukin-31RA, and OSMR Expression Levels in Post-burn Hypertrophic Scars
by: Mi Young Lee, et al.
Published: (2018-09-01)

HIGH LEVEL OF IL -1 RECEPTOR ANTAGONIST AS A LETHALITY FACTOR IN PATIENTS WITH SURGICAL SEPSIS
by: V. V. Grebenyuk, et al.
Published: (2014-07-01)

Polymorphisms in the TGFB1 and IL2RA genes are associated with clinical forms of leprosy in Brazilian population
by: Rodrigo Mendes de Camargo, et al.
Published: (2018-12-01)

Effect of hypothermia on interleukin-1 receptor antagonist pharmacodynamics in inflammatory-sensitized hypoxic-ischemic encephalopathy of term newborns
by: Mathilde Chevin, et al.
Published: (2018-07-01)

A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis
by: Jia Li, et al.
Published: (2021-06-01)

Low plasma levels of IGF-1 and IL-1RA with high plasma levels of IFN-γ as prognostic factor for mortality in hospitalized geriatric patients with delirium
by: I Nyoman Astika, et al.
Published: (2019-07-01)